CRSP Smart Money
CRISPR Therapeutics AG
1W: -2.1%
1M: -9.6%
3M: +3.1%
YTD: -8.8%
1Y: -27.1%
3Y: +23.2%
5Y: -49.1%
$51.47
+2.46 (+5.02%)
After Hours: $51.43 (-0.04, -0.08%)
Weekly Expected Move ±6.6%
$43
$46
$49
$53
$56
Credit Risk of going bust: higher than 50% of companies Debt: 14.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.69 (down 99%), CRISPR Therapeutics AG would be worth roughly what it owes.
Total debt $783.7M against a stock market value of $4.74B.
Distance to default 5.09 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $293.1M (short-term plus half of long-term), stock volatility 57.0%; Altman Z'' 3.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $783.7M against a stock market value of $4.74B.
Distance to default 5.09 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $293.1M (short-term plus half of long-term), stock volatility 57.0%; Altman Z'' 3.71. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026576
Institutions Holding
+11 vs prior
86.4%
Ownership
+10.53%
83
New
155
Increased
190
Reduced
48
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-10-19 | Kulkarni Samarth | officer: chief executive officer | S-Sale | 47,837 | $49.78 | $2.4M | Filing |
| 2026-10-14 | George Simeon | director | S-Sale | 14,514 | $49.63 | $720K | Filing |
| 2026-10-14 | Kulkarni Samarth | officer: chief executive officer | S-Sale | 4,098 | $49.26 | $202K | Filing |
| 2026-10-14 | KASINGER JAMES R. | officer: general counsel and secretary | S-Sale | 1,040 | $49.26 | $51K | Filing |
| 2026-10-06 | KASINGER JAMES R. | officer: general counsel and secretary | S-Sale | 1,990 | $60.04 | $119K | Filing |
| 2026-09-22 | KASINGER JAMES R. | officer: general counsel and secretary | S-Sale | 10,400 | $60.24 | $626K | Filing |
| 2026-09-17 | Behbahani Ali | director | S-Sale | 13,679 | $57.09 | $781K | Filing |
| 2026-08-07 | Prasad Raju | officer: chief financial officer | G-Gift | 750 | $— | $0 | Filing |
| 2026-05-29 | Patel Naimish | officer: chief medical officer | S-Sale | 3,786 | $55.62 | $211K | Filing |
| 2026-03-23 | Prasad Raju | officer: chief financial officer | S-Sale | 3,708 | $46.78 | $173K | Filing |
| 2026-03-23 | Kulkarni Samarth | officer: chief executive officer | S-Sale | 10,020 | $46.78 | $469K | Filing |
| 2026-03-23 | KASINGER JAMES R. | officer: general counsel and secretary | S-Sale | 3,182 | $46.78 | $149K | Filing |
| 2026-03-16 | Kulkarni Samarth | officer: chief executive officer | S-Sale | 10,349 | $48.26 | $499K | Filing |
| 2026-03-16 | KASINGER JAMES R. | officer: general counsel and secretary | S-Sale | 3,450 | $48.26 | $166K | Filing |
| 2026-03-16 | Prasad Raju | officer: chief financial officer | G-Gift | 750 | $— | $0 | Filing |
| 2026-03-16 | Prasad Raju | officer: chief financial officer | S-Sale | 4,021 | $48.26 | $194K | Filing |
| 2026-03-16 | Prasad Raju | officer: chief financial officer | S-Sale | 5,848 | $48.26 | $282K | Filing |
| 2026-03-16 | Patel Naimish | officer: chief medical officer | S-Sale | 3,150 | $48.26 | $152K | Filing |
| 2026-03-11 | Kulkarni Samarth | officer: chief executive officer | S-Sale | 9,798 | $52.80 | $517K | Filing |
| 2026-03-11 | KASINGER JAMES R. | officer: general counsel and secretary | S-Sale | 2,800 | $52.80 | $148K | Filing |
| 2026-02-19 | Kulkarni Samarth | officer: chief executive officer | S-Sale | 6,967 | $52.58 | $366K | Filing |
| 2026-02-19 | KASINGER JAMES R. | officer: general counsel and secretary | S-Sale | 2,112 | $52.58 | $111K | Filing |
| 2026-01-22 | Prasad Raju | officer: chief financial officer | S-Sale | 34,972 | $60.19 | $2.1M | Filing |
| 2026-01-22 | Kulkarni Samarth | officer: chief executive officer | S-Sale | 60,000 | $60.23 | $3.6M | Filing |
| 2026-01-20 | Kulkarni Samarth | officer: chief executive officer | S-Sale | 21,433 | $51.61 | $1.1M | Filing |
🏛️ Congressional Trades
10 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| 2021-09-20 | Thomas Suozzi | House | Sell | $50,001 - $100,000 | Filing |
| 2021-01-21 | Marjorie Taylor Greene | House | Buy | $1,001 - $15,000 | Filing |
| 2021-01-05 | James Inhofe | Senate | Sell | $1,001 - $15,000 | Filing |
| 2021-01-05 | James Inhofe | Senate | Sell | $1,001 - $15,000 | Filing |
| 2020-12-22 | James Inhofe | Senate | Sell | $50,001 - $100,000 | Filing |
| 2020-12-22 | James Inhofe | Senate | Sell | $50,001 - $100,000 | Filing |
| 2018-06-19 | James Inhofe | Senate | Sell | $15,001 - $50,000 | Filing |
| 2018-06-19 | James Inhofe | Senate | Sell | $15,001 - $50,000 | Filing |
| 2017-10-19 | James Inhofe | Senate | Buy | $15,001 - $50,000 | Filing |
| 2017-10-19 | James Inhofe | Senate | Buy | $15,001 - $50,000 | Filing |
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 9,460,939 | $516M | -1,852,684 | 2026-06-30 | Filing |
| BlackRock, Inc. | 8,348,977 | $455M | +668,904 | 2026-06-30 | Filing |
| Orbis Allan Gray Ltd | 5,449,161 | $297M | -656,850 | 2026-06-30 | Filing |
| Capital World Investors | 4,749,525 | $259M | +24,488 | 2026-06-30 | Filing |
| STATE STREET CORP | 4,321,666 | $236M | +339,166 | 2026-06-30 | Filing |
| GSK plc | 3,220,627 | $176M | — | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2,509,915 | $137M | +132,751 | 2026-06-30 | Filing |
| SR One Capital Management, LP | 2,038,763 | $111M | — | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 1,988,621 | $108M | +505,570 | 2026-06-30 | Filing |
| FMR LLC | 1,908,503 | $104M | -46,191 | 2026-06-30 | Filing |
| Sumitomo Mitsui Trust Group, Inc. | 1,720,734 | $94M | -133,141 | 2026-06-30 | Filing |
| Amova Asset Management Americas, Inc. | 1,720,097 | $94M | -133,778 | 2026-06-30 | Filing |
| EcoR1 Capital, LLC | 1,389,276 | $76M | — | 2026-06-30 | Filing |
| UBS Group AG | 1,317,499 | $72M | -445,031 | 2026-06-30 | Filing |
| Capital International Investors | 1,268,407 | $69M | +81,613 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,181,847 | $64M | +39,304 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 1,155,105 | $63M | +172,033 | 2026-06-30 | Filing |
| NEA Management Company, LLC | 1,058,570 | $58M | — | 2026-06-30 | Filing |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,057,837 | $58M | +18,488 | 2026-06-30 | Filing |
| Sixth Street Partners Management Company | 1,057,837 | $58M | +1,057,837 | 2026-06-30 | Filing |